The Hermansky–Pudlak syndrome market is evolving as research into targeted therapies for rare pigmentation and platelet disorders progresses, supported by improved diagnosis and orphan drug development. https://www.datamintelligence.com/research-report/hermansky-pudlak-syndrome-market